Search

Pages

1. • Journal article

   • 

   Healthcare consumption and direct costs of rheumatoid arthritis in Belgium

   Westhovens, Rene[UCL] Durez, Patrick[UCL] Boonen, Anne[UCL] Verbruggen, L. De Clerck, L. Malaise, Michel Mielants, H. (2005) Clinical Rheumatology — Vol. 24, no. 6, p. 615-619 (2005)
2. • Speech

   • 

   The efficacy and safety of abatacept in methotrexate-naive patients with early erosive rheumatoid arthritis and poor prognostic factors

   Westhovens, Rene[UCL] Durez, Patrick[UCL] Robles, M. Nayiager, S. Wollenhaupt, J. Gomez-Reino, J. Grassi, W. Haraoui, B. Shergy, W. Park, S. H. Genant, H. Peterfy, C. Becket, J-C. Covucci, A. Helfirick, R. Bathon, J. (2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — San Francisco (Ca)
3. • Speech

   • 

   A phase I study comparing the safety, pharmacokinetics, and pharmacodynamics of infliximab administered by the subcutaneous, intravenous followed by subcutaneous, or intramuscular routes of administration in rheumatoid arthritis patients.

   Westhovens, Rene[UCL] Durez, Patrick[UCL] Hollssiau, FA Daniel, EE Bouman-Thio, E Sisco, D van Hartingsveldt, B Mascelli, MA Zhu, YW Graham, MA Joly, Jeroen[UCL] (2004) 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — San Antonio (Tx)
4. • Speech

   • 

   Disease Remission is Achieved Within Two Years In Over Half of Methotrexate Naive Patients with Early Erosive Rheumatoid Arthritis (RA) Treated with Abatacept Plus MTX: Results from The AGREE Trial

   Haraoui, Boulos Durez, Patrick[UCL] Westhovens, Rene[UCL] Robles, Manuel Nayiager, Sauithree Wollenhaupt, Jurgen Gomez-Reino, J. Grassi, Walter Shergy, William Park, Sung-Hwan Genant, Harry Peterfy, Charles Becker, Jean-Claude Covucci, Allison Bathon, Joan Helfrick, Roy (2010) 65th Annual Meeting of the Canadian-Rheumatology-Association — Quebec (Canada)
5. • Speech

   • 

   A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks is effective: A Belgian prospective study

   Westhovens, Rene[UCL] Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Vastesaeger, N. (2004) Annual European Congress of Rheumatology (EULAR 2004) — Berlin (Germany)
6. • Journal article

   • 

   Further international adaptation and validation of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire

   Wilburn, Jeanette McKenna, Stephen P Twiss, James Rouse, Matthew Korkosz, Mariusz Jancovic, Roman Nemec, Petr Pacheco-Tena, César Francisco Saraux, Alain Westhovens, Rene Durez, Patrick[UCL] Martin, Mona Tammaru, Marika (2015) Rheumatology International : clinical and experimental investigations — Vol. 35, no. 4, p. 669-675 (2015)
7. • Journal article

   • 

   Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry

   De Keyser, Filip Hoffman, Ilse Durez, Patrick[UCL] Kaiser, Marie-Joëlle Westhovens, Rene MIRA Study Group (2014) Journal of Rheumatology — Vol. 41, no. 9, p. 1761-1765 (2014)
8. • Journal article

   • 

   DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

   Cruyssen, BV Van Looy, S. Wyns, B Westhovens, Rene[UCL] Durez, Patrick[UCL] Van den Bosch, F. Veys, Éric M. Mielants, H. DE Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaeger, N. Geldhof, A. Boullart, L. De Keyser, F. (2005) Arthritis Research & Therapy — Vol. 7, no. 5, p. R1063-R1071 (2005)
9. • Journal article

   • 

   Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ

   Put, Karen Avau, Anneleen Brisse, Ellen Mitera, Tania Put, Stéphanie Proost, Paul Bader-Meunier, Brigitte Westhovens, Rene Van den Eynde, Benoît[UCL] Orabona, Ciriana Fallarino, Francesca De Somer, Lien Tousseyn, Thomas Quartier, Pierre Wouters, Carine Matthys, Patrick (2015) Rheumatology — Vol. 54, no. 8, p. 1507-1517 (2015)
10. • Speech

    • 

    Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect

    Cruyssen, B. Vander Durez, Patrick[UCL] Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaegere, N. Geldhof, A. De Keyser, F. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
11. • Journal article

    • 

    Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study

    Durez, Patrick[UCL] Westhovens, Rene Baeke, Femke Elbez, Yedid Robert, Sofie Ahmad, Harris A. (2022) BMC Rheumatology — Vol. 6, no.1, p. 1-9 (2022)
12. • Journal article

    • 

    High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis

    De Decker, Evelien Vanthuyne, Marie[UCL] Blockmans, Daniel Houssiau, Frédéric[UCL] Lenaerts, Jan Westhovens, Rene Nemery, Benoit De Langhe, Ellen (2018) Clinical Rheumatology — Vol. 37, no. 7, p. 1977-1982 (2018)
13. • Journal article

    • 

    Timing of DAS28 in infliximab therapy: reply

    Durez, Patrick[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Vastesaeger, N. Geldhof, A. Westhovens, Rene[UCL] (2005) Rheumatology — Vol. 44, no. 9, p. 1204-1204 (2005)
14. • Journal article

    • 

    Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment

    Van Looy, Stijn Durez, Patrick[UCL] Cruyssen, Bert Vander Meeus, Jeroen Wyns, Bart Westhovens, Rene Van den Bosch, Filip Vastesaeger, Nathan Geldhof, Anja Boullart, Luc De Keyser, Filip (2006) Engineering Applications of Artificial Intelligence — Vol. 19, no. 7, p. 819-828 (2006)
15. • Speech

    • 

    Genetic variation in the TNFRSF11A (RANK) gene contributes to the risk to develop sporadic Paget's disease of bone

    Chung, P. Y. J. Devogelaer, Jean-Pierre[UCL] Beyens, G. Riches, P. L. Van Wesenbeeck, L. Jennes, K. Daroszewska, A. Boonen, S.[UCL] Geusens, R. Vanhoenacker, F. Verbruggen, L. Van Offel, J. Goemaere, S. Zmierczak, H. Westhovens, Rene[UCL] Karperien, M. Papapoulos, S. Ralston, S. H. Van Hul, W. (2009) 36th European Symposium on Calcified Tissues — Vienna (Austria)
16. • Journal article

    • 

    Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

    Cruyssen, Bert Vander Van Looy, Stijn Wyns, Bart Westhovens, Rene Durez, Patrick[UCL] Van den Bosch, Filip Mielants, Herman De Clerck, Luc Peretz, Ann Malaise, Michel Verbruggen, Leon Vastesaeger, Nathan Geldhof, Anja Boullart, Luc De Keyser, Filip (2006) Arthritis Research & Therapy (Online) — Vol. 8, no. 4, p. R112 [1-7] (2006)
17. • Journal article

    • 

    Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails? Reply

    Durez, Patrick[UCL] Nzeusseu, TA Lauwerys, Bernard[UCL] Manicourt, Daniel[UCL] Devogelaer, Jean-Pierre[UCL] Houssiau, Frédéric[UCL] Verschueren, P. Westhovens, Rene[UCL] (2005) Annals of the Rheumatic Diseases — Vol. 64, no. 3, p. 512-512 (2005)
18. • Journal article

    • 

    Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.

    Vandecasteele, Els Melsens, Karin Vanhaecke, Amber Blockmans, Daniel Bonroy, Carolien Carton, Charlotte Deschepper, Ellen De Keyser, Filip Houssiau, Frédéric[UCL] Piette, Yves Vanthuyne, Marie[UCL] Verbeke, Koen Westhovens, Rene Wuyts, Wim A De Langhe, Ellen Brusselle, Guy Smith, Vanessa (2021) Seminars in arthritis and rheumatism — Vol. 51, no. 5, p. 969-976 (2021)
19. • Journal article

    • 

    A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.

    Durez, Patrick[UCL] Nzeusseu Toukap, A Lauwerys, Bernard[UCL] Manicourt, Daniel[UCL] Verschueren, P. Westhovens, Rene[UCL] Devogelaer, Jean-Pierre[UCL] Houssiau, Frédéric[UCL] (2004) Annals of the rheumatic diseases — Vol. 63, no. 9, p. 1069-74 (2004)
20. • Speech

    • 

    The Efficacy and Safety of Abatacept in Methotrexate-naive Patients with Early Erosive Rheumatoid Arthritis and Poor Prognostic Factors

    Haraoui, B. Durez, Patrick[UCL] Westhovens, Rene[UCL] Robles, M. Nayiager, S. Wollenhaupt, J. Gomez-Reino, J. Grassi, W. Shergy, W. Park, S. H. Genant, H. Peterfy, C. Becker, J-C. Covucci, A. Helfrick, R. Bathon, J. (2009) 64th Annual Meeting/17th Winter Workshop of the Canadian-Rheumatology-Association — Kananaskis (Canada)
21. • Speech

    • 

    Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA)

    Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Vander Cruyssen, B. Vandenbosch, F. Vastesaeger, N. Geldhof, A. De Keyser, F. Verbruggen, L. De Clerck, L. Peretz, A. Malaise, Michel Van Heuverbeke, F. Westhovens, Rene[UCL] (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
22. • Journal article

    • 

    Founder effect in different European countries for the recurrent P392L SQSTM1 mutation in Paget's disease of bone

    Chung, Pui Yan Jenny Devogelaer, Jean-Pierre[UCL] Beyens, Greet Guanabens, Nuria Boonen, Steven Papapoulos, Socrates Karperien, Marcel Eekhoff, Marelise Van Wesenbeeck, Liesbeth Jennes, Karen Geusens, Piet Offeciers, Erwin Van Offel, Jan Westhovens, Rene Zmierczak, Hans Van Hul, Wim (2008) Calcified Tissue International — Vol. 83, no. 1, p. 34-42 (2008)
23. • Speech

    • 

    Evaluation of the DAS28 at week 14 or week 22 correlates best with long term attrition to infliximab therapy in rheumatoid arthritis patients

    Cruyssen, B. Vander Durez, Patrick[UCL] Van Looy, S. Wijns, B. Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaeger, N. Geldhof, A. Boullart, L. De Keyser, F. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
24. • Speech

    • 

    Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

    Vander Cruyssen, B. Durez, Patrick[UCL] Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Dewulf, L. Vastesaeger, N. Geldhof, A. Noel, W. Boullart, L.[UCL] De Keyser, F. (2008) —
25. • Speech

    • 

    A prospective randomised comparative study of the short-term effects of infliximab (remicade) and intravenous pulse methylprednisolone in rheumatoid arthritis patients with active disease despite methotrexate

    Durez, Patrick[UCL] Toukap, AN Lauwerys, Bernard[UCL] Westhovens, Rene[UCL] Houssiau, Frédéric[UCL] (2003) Annual European Congress of Rheumatology — LISBON (Portugal)

Pages